Cart
sales@molnova.com
RN-1665
CAS No. 1803003-65-7
RN-1665( —— )
Catalog No. M37081 CAS No. 1803003-65-7
RN-1665 is a potent and selective TRPV4 receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 157 | In Stock |
|
| 10MG | 216 | In Stock |
|
| 25MG | 357 | In Stock |
|
| 50MG | 463 | In Stock |
|
| 100MG | 637 | In Stock |
|
| 200MG | 840 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRN-1665
-
NoteResearch use only, not for human use.
-
Brief DescriptionRN-1665 is a potent and selective TRPV4 receptor antagonist.
-
DescriptionRN-1665 is a potent and selective TRPV4 receptor antagonist.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRP/TRPV Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1803003-65-7
-
Formula Weight513.54
-
Molecular FormulaC20H24F5N3O3S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC=C(S(N2CCN(C(C)C)CC2)(=O)=O)C=C1)C3=CC=C(S(F)(F)(F)(F)F)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
TRPV3 antagonist 74a
TRPV3 antagonist 74a (TRPV3 74a) is a specific TRPV3 antagonist for the study of neurological disorders.
-
EIPA
EIPA (L593754, MH 12-43) is a TRPP3 channel inhibitor (IC50: 10.5 μM). It also inhibits Na+/H+-exchanger (NHE) and macropinocytosis.It is found that EIPA, benzamil, and phenamil rapidly and reversibly block Ca2+-activated TRPP3 channel activation at -50 mV, with IC50s of 143, 10.5, 1.1, and 0.14 μM, respectively.
-
AM-0902
AM-0902 is a potent and specific TRPA1 antagonist (IC50s: 71/131 nM for rTRPA1 and hTRPA1).
